Aquestive Therapeutics, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
5.50
|
|
Average Rating
|
4.57
|
|
# Strong Buys
|
4
|
|
# Buys
|
3
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.31
|
-0.23
|
0.08
|
25.81%
|
|
2022-06-30
|
-0.36
|
-0.36
|
0.00
|
0.00%
|
|
2022-03-31
|
-0.41
|
-0.32
|
0.09
|
21.95%
|
|
2021-12-31
|
-0.47
|
-0.38
|
0.09
|
19.15%
|
|
2021-09-30
|
-0.45
|
-0.37
|
0.08
|
17.78%
|
|
2021-06-30
|
-0.44
|
-0.33
|
0.11
|
25.00%
|
|
2021-03-31
|
-0.43
|
-0.41
|
0.02
|
4.65%
|
|
2020-12-31
|
-0.26
|
-0.60
|
-0.34
|
-130.77%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-0.91
|
|
2021-12-31
|
-1.49
|
|
2020-12-31
|
-1.65
|
|
2019-12-31
|
-2.63
|
|
2018-12-31
|
-3.83
|